ONCT logo

Oncternal Therapeutics (ONCT)

Profile

Full Name

Oncternal Therapeutics, Inc.

Ticker Symbol

ONCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 3, 2004

Indexes

Not included

Website

http://www.oncternal.com

Employees

27

Key Details

Price

$0.53(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$13.43(+20.06% YoY)

PE ratio

-

Next earnings date

Apr 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.53
ONCT price is $0.53

30-Day Relative Volume

-
ONCT 30-day relative volume value is unknown

Price Performance

Price Most recent change

0%
ONCT {parameterFullLabel} has remained unchanged on Apr 16, 2025

Price YTD change

0%
ONCT {parameterFullLabel} has remained unchanged since January 1st

Price 1-year change

-94.12%
ONCT price is down -94.12% year-on-year

Price 3-year change

-97.71%
ONCT price is down -97.71% over the past 3 years

Price Range

Price All-time high

$33096.00
ONCT price is currently -100.00% below its historical high of $33096.00

Price 3-year low

$0.53
ONCT price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.56M
ONCT market capitalization is $1.56 million

Market cap 3-year change

-97.26%
ONCT market capitalization is down -97.26% over the past 3 years

Market cap All-time high

$815.03M
ONCT market capitalization is currently -99.81% below its historical high of $815.03 million

Market cap sector rank

5.92%
ONCT market capitalization is higher than 5.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
ONCT {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+19.75%
ONCT shares outstanding is up +19.75% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.03
ONCT beta is 0.03

200-day SMA

$2.07
ONCT price is currently -74.51% below its 200-day simple moving average

50-day SMA

$0.53
ONCT price is currently equal to its 50-day simple moving average

RSI

50.00
ONCT 14-day relative strength index is 50.00

Volume

-
ONCT 30-day relative volume value is unknown

ATR

$0.00
ONCT average true range is $0.00

10-day Historical Volatility

0.00%
ONCT 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ONCT annual revenue value is unknown

Revenue Analysts estimate

$1.92M
ONCT annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ONCT annual revenue 1-year change is unknown

Revenue Sector rank

-
ONCT annual revenue is unknown

EPS

EPS

-$13.43
ONCT annual earnings per share is -$13.43

EPS Analysts estimate

-$12.43
ONCT annual earnings per share is currently +8.05% higher than the consensus analysts' forecast

EPS 1-year change

+20.06%
ONCT annual earnings per share is up +20.06% year-on-year

EPS Sector rank

9.67%
ONCT annual earnings per share is higher than 9.67% of companies in Healthcare sector

Profit

Gross profit

-
ONCT annual gross profit value is unknown

Gross margin

-
ONCT annual gross profit margin value is unknown

Operating profit

-$41.71M
ONCT annual operating income is -$41.71 million

Operating margin

-
ONCT annual operating profit margin value is unknown

Net income

-$39.48M
ONCT annual net profit is -$39.48 million

Net margin

-
ONCT annual net profit margin value is unknown

Expenses

Total expenses

$41.71M
ONCT annual total expenses is $41.71 million

Operating expenses

$41.71M
ONCT annual total operating expenses is $41.71 million

Cost of goods sold

-
ONCT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.75M
ONCT annual SGA is $12.75 million

Depreciation and amortization

-
ONCT annual depreciation & amortization value is unknown

Interest expense

-
ONCT annual interest expense value is unknown

Income tax

-
ONCT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$41.71M
ONCT annual earnings before interest & taxes is -$41.71 million

EBITDA

-$41.71M
ONCT annual EBITDA is -$41.71 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$36.73M
ONCT annual total assets is $36.73 million

Non current assets

$670.00K
ONCT annual long term assets is $670.00 thousand

Current assets

$36.06M
ONCT annual total current assets is $36.06 million

Cash and cash equivalents

$6.70M
ONCT annual cash & cash equivalents is $6.70 million

Accounts receivable

-
ONCT annual accounts receivable value is unknown

Inventory

-
ONCT annual inventory value is unknown

Liabilities

Total liabilities

$6.68M
ONCT annual total liabilities is $6.68 million

Long term liabilities

$1.48M
ONCT annual total long term liabilities is $1.48 million

Current liabilities

$5.20M
ONCT annual total current liabilities is $5.20 million

Accounts payable

$1.15M
ONCT annual accounts payable is $1.15 million

Debt

Total debt

$318.00K
ONCT annual total debt is $318.00 thousand

Total debt 1-year change

+265.52%
ONCT annual total debt is up +265.52% year-on-year

Long term debt

$145.00K
ONCT annual long term debt is $145.00 thousand

Short term debt

$173.00K
ONCT annual short term debt is $173.00 thousand

Equity & Capital

Shareholders equity

$30.05M
ONCT annual stockholders equity is $30.05 million

Book value

$30.05M
ONCT annual book value is $30.05 million

Retained earnings

-$197.78M
ONCT annual retained earnings is -$197.78 million

Working capital

$30.86M
ONCT annual working capital is $30.86 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$32.16M
ONCT annual cash flow from operations is -$32.16 million

Cash from operations 1-year change

+12.37%
ONCT annual cash flow from operations is up +12.37% year-on-year

Cash from investing

$651.00K
ONCT annual cash flow from investing activities is $651.00 thousand

Cash from investing 1-year change

+102.46%
ONCT annual cash flow from investing activities is up +102.46% year-on-year

Cash from financing

$1.07M
ONCT annual cash flow from financing activities is $1.07 million

Cash from financing 1-year change

-88.85%
ONCT annual cash flow from financing activities is down -88.85% year-on-year

CAPEX

CAPEX

-
ONCT annual capital expenditures value is unknown

CAPEX 1-year change

-
ONCT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$32.16M
ONCT annual free cash flow is -$32.16 million

Free cash flow 1-year change

+12.37%
ONCT annual free cash flow is up +12.37% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ONCT annual gross profit margin value is unknown

Operating margin

-
ONCT annual operating profit margin value is unknown

Net margin

-
ONCT annual net profit margin value is unknown

ROA & ROE

ROA

-107.49%
ONCT annual return on assets is -107.49%

ROE

-131.37%
ONCT annual return on equity is -131.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ONCT price to earnings ratio value is unknown

PE ratio Sector rank

-
ONCT price to earnings ratio is unknown

PB Ratio

PB ratio

0.17
ONCT price to book ratio is 0.17

PB ratio Sector rank

18.86%
ONCT price to book ratio is higher than 18.86% of companies in Healthcare sector

PS Ratio

PS ratio

-
ONCT price to sales ratio value is unknown

PS ratio Sector rank

-
ONCT price to sales ratio is unknown

Enterprise value

Enterprise value

-$11.33M
ONCT enterprise value is -$11.33 million

Enterprise value Sector rank

4.21%
ONCT enterprise value is higher than 4.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.32
ONCT EV/EBITDA is 0.32

EV/EBITDA Sector rank

70.52%
ONCT EV/EBITDA is higher than 70.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.94
ONCT annual current ratio is 6.94

Quick ratio

-
ONCT annual quick ratio value is unknown

Leverage

Debt to equity

0.01
ONCT annual debt to equity ratio is 0.01

Interest coverage ratio

-
ONCT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ONCT piotroski f-score value is unknown

Altman Z-Score

-
ONCT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Aug 12, 24 HC Wainwright & Co.
Buy
Jul 16, 24 HC Wainwright & Co.
Buy
May 31, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Apr 15, 24 HC Wainwright & Co.
Buy
Jan 29, 24 HC Wainwright & Co.
Buy
Dec 27, 23 HC Wainwright & Co.
Buy
Dec 4, 23 Brookline Capital
Buy
Sep 18, 23 HC Wainwright & Co.
Buy
Sep 7, 23 Cantor Fitzgerald
Neutral

Institutional Ownership

Similar stocks

HSDT logo
Helius Medical Technologies (HSDT)
Polyrizon (PLRZ)
AKAN logo
Akanda (AKAN)
AVGR logo
Avinger (AVGR)
Syra Health Corp Class A (SYRA)
Scinai Immunotherapeutics (SCNI)
VINC logo
Vincerx Pharma (VINC)
AWH logo
Aspira Womens Health (AWH)
UPC logo
Universe Pharmaceuticals (UPC)
  • What is the ticker symbol for Oncternal Therapeutics?
  • Does Oncternal Therapeutics pay dividends?
  • What sector is Oncternal Therapeutics in?
  • What industry is Oncternal Therapeutics in?
  • What country is Oncternal Therapeutics based in?
  • When did Oncternal Therapeutics go public?
  • Is Oncternal Therapeutics in the S&P 500?
  • Is Oncternal Therapeutics in the NASDAQ 100?
  • Is Oncternal Therapeutics in the Dow Jones?
  • When was Oncternal Therapeutics's last earnings report?
  • When does Oncternal Therapeutics report earnings?
  • Should I buy Oncternal Therapeutics stock now?

What is the ticker symbol for Oncternal Therapeutics?

The ticker symbol for Oncternal Therapeutics is NASDAQ:ONCT

Does Oncternal Therapeutics pay dividends?

No, Oncternal Therapeutics does not pay dividends

What sector is Oncternal Therapeutics in?

Oncternal Therapeutics is in the Healthcare sector

What industry is Oncternal Therapeutics in?

Oncternal Therapeutics is in the Biotechnology industry

What country is Oncternal Therapeutics based in?

Oncternal Therapeutics is headquartered in United States

When did Oncternal Therapeutics go public?

Oncternal Therapeutics's initial public offering (IPO) was on February 3, 2004

Is Oncternal Therapeutics in the S&P 500?

No, Oncternal Therapeutics is not included in the S&P 500 index

Is Oncternal Therapeutics in the NASDAQ 100?

No, Oncternal Therapeutics is not included in the NASDAQ 100 index

Is Oncternal Therapeutics in the Dow Jones?

No, Oncternal Therapeutics is not included in the Dow Jones index

When was Oncternal Therapeutics's last earnings report?

Oncternal Therapeutics's most recent earnings report was on Nov 6, 2024

When does Oncternal Therapeutics report earnings?

The next expected earnings date for Oncternal Therapeutics is Apr 18, 2025

Should I buy Oncternal Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page